Amgen is a biotechnology company. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses such as cancer, inflammation, nephrology and bone diseases.
Company Growth (employees)
Thousand Oaks, US
Size (employees)
17,900 (est)-6%
Amgen was founded in 1980 and is headquartered in Thousand Oaks, US

Key People at Amgen

Robert A. Bradway

Robert A. Bradway

Chairman and Chief Executive Officer
Suzanne Blaug

Suzanne Blaug

SVP, Global Marketing and Commercial Development

Amgen Office Locations

Amgen has offices in Thousand Oaks, San Francisco, South San Francisco, Bucharest and in 59 other locations
Thousand Oaks, US (HQ)
One Amgen Center Drive

Amgen Data and Metrics

Amgen Financial Metrics

Amgen's revenue was reported to be $23 b in FY, 2016 which is a 6% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

23 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

18.8 b

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

7.7 b

EBIT (FY, 2016)

9.8 b

Market capitalization (23-May-2017)

113.3 b

Closing share price (23-May-2017)


Cash (31-Dec-2016)

3.2 b


144.7 b
Amgen's current market capitalization is $113.3 b.
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016


18.7 b20.1 b21.7 b23 b

Revenue growth, %


Cost of goods sold

3.3 b4.4 b4.2 b4.2 b

Gross profit

15.3 b15.6 b17.4 b18.8 b

Gross profit Margin, %


Operating expense total

12.8 b13.9 b13.2 b13.2 b


5.9 b6.2 b8.5 b9.8 b

EBIT margin, %


Interest expense

1 b1.1 b1.1 b1.3 b

Pre tax profit

5.3 b5.6 b8 b9.2 b

Income tax expense

184 m427 m1 b1.4 b

Net Income

5.1 b5.2 b6.9 b7.7 b
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016


3.8 b3.7 b4.1 b3.2 b

Accounts Receivable

2.7 b2.5 b3 b3.2 b


3 b2.6 b2.4 b2.7 b

Current Assets

27.4 b34.7 b38.5 b46 b


5.3 b5.2 b4.9 b5 b


15 b14.8 b14.8 b14.8 b

Total Assets

66.1 b69 b71.6 b77.6 b

Accounts Payable

787 m1.2 b965 m917 m

Total Debt

32.1 b30.7 b31.6 b34.6 b

Current Liabilities

7.9 b7 b8.7 b11.2 b

Common Stock

30.8 b

Retained Earnings

(7.6 b)(4.6 b)(2.1 b)(438 m)

Total Equity

28.1 b29.9 b

Debt to Equity Ratio

1.1 x1.2 x

Debt to Assets Ratio

0.5 x0.4 x0.4 x0.4 x

Financial Leverage

2.5 x2.6 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

5.1 b5.2 b6.9 b7.7 b

Accounts Receivable

(38 m)136 m(420 m)(214 m)


(7 m)327 m481 m(80 m)

Accounts Payable

(184 m)405 m(12 m)(44 m)

Cash From Operating Activities

6.3 b8.6 b9.1 b10.4 b

Purchases of PP&E

(693 m)(718 m)(594 m)(738 m)

Cash From Investing Activities

(8.5 b)(5.8 b)(5.5 b)(8.7 b)

Long-term Borrowings

(3.4 b)(5.6 b)(2.4 b)(3.7 b)

Dividends Paid

(1.4 b)(1.9 b)(2.4 b)(3 b)

Cash From Financing Activities

2.7 b(2.9 b)(3.1 b)(2.6 b)
Numbers are in $, USDY, 2016


14.8 x


14 x


1.2 m


1.2 x


0.4 x

Financial Leverage

2.6 x

Amgen Market Value History

Amgen Job Categories

Amgen Median Salaries

Source: 437 public H-1B filings from Amgen

Amgen Online and Social Media Presence

Amgen News and Updates

Amgen Company Life and Culture

You may also be interested in